XMFstockpicker

Peter Stephens

XMFstockpicker’s Activity

Wed Apr 16

NL

Article

TMFstockpicker published an article 10:04 AM

This Is Dividend Stock Johnson & Johnson’s Major Weakness

Although diversification can sometimes be a strength, it can also prove to be a double-edged sword in the long run. Here’s how.

Tue Apr 15

NL

Article

TMFstockpicker published an article 8:28 AM

Johnson & Johnson's 3 Major Strengths

What are the three key reasons why J&J could be a top performer in the future?

Wed Apr 2

NL

Article

TMFstockpicker published an article 1:22 PM

Can J&J's Pharma Segment Deliver Meaningful Growth?

In the final part of a three-part series, I take a deep dive into J&J's pharmaceuticals segment and ask whether it's as attractive as many investors believe.

Thu Mar 27

NL

Article

TMFstockpicker published an article 1:42 PM

Don't Underestimate J&J's Best-Known Products

In the second of a three-part series I take a closer look at J&J's (NYSE: JNJ) consumer segment to find out if it could make the stock take off.

Mon Mar 24

NL

Article

TMFstockpicker published an article 1:06 PM

Is J&J's Forgotten Half About to Take Off?

In the first of a three-part series, I put Johnson & Johnson's medical devices and diagnostics segment under the investment microscope.

Thu Mar 20

NL

Article

TMFstockpicker published an article 9:30 AM

Is Novartis' Strategy a Winning One?

Novartis has changed to a new strategy. Is it likely to be a successful one?

Wed Mar 19

NL

Article

TMFstockpicker published an article 9:30 AM

Better Buy: GlaxoSmithKline, AbbVie, or Merck?

Shares in GlaxoSmithKline have underperformed the index in recent years. Does this mean the stock is undervalued?

Tue Mar 18

NL

Article

TMFstockpicker published an article 4:52 PM

Is Procter & Gamble a Buy at Current Levels?

With shares disappointing in recent years, is Procter & Gamble now attractive?

NL

Article

TMFstockpicker published an article 3:16 PM

Why Philip Morris Could Be a Winning Stock

Philip Morris could be a strong performer in future. Here's why.

NL

Article

TMFstockpicker published an article 9:30 AM

Does Bristol-Myers Squibb Offer Good Value?

Having had a strong performance in recent years, does Bristol-Myers Squibb still offer good value for your money at current price levels?

Mon Mar 17

NL

Article

TMFstockpicker published an article 9:30 AM

Can Pfizer Outperform in 2014?

After tracking the index for five years, Pfizer could be worth buying. Here's why.

Fri Mar 14

NL

Article

TMFstockpicker published an article 6:30 PM

Can AbbVie Continue Its Bull Run?

After an impressive share price performance since it listed, is AbbVie still worth buying?

Thu Mar 13

NL

Article

TMFstockpicker published an article 9:30 AM

Can Eli Lilly Continue its Bull Run?

Despite some disappointing news, Eli Lilly's stock has made a strong start to 2014. Can it keep going?

Wed Mar 12

NL

Article

TMFstockpicker published an article 6:30 PM

Bristol-Myers Squibb: More Than Just a Relief Rally?

Shares in Bristol-Myers Squibb performed relatively positively last week. Can they keep it going?

Tue Mar 11

NL

Article

TMFstockpicker published an article 8:58 PM

Is Merck a Buy at Current Price Levels?

After a strong recent run, are shares in Merck (NYSE: MRK) still worth buying?

Sun Mar 9

NL

Article

TMFstockpicker published an article 7:00 AM

Has Celgene Corporation Run Out of Steam in 2014?

After an awesome 2013, Celgene (NASDAQ: CELG) has made a bad start to the year. Can it recover?

Fri Mar 7

NL

Article

TMFstockpicker published an article 1:48 PM

Can Merck Keep Its Bull Run Going?

Shares in Merck have made a strong start to 2014. Can they keep going?

Wed Mar 5

NL

Article

TMFstockpicker published an article 11:36 AM

Can Roche Keep Its Bull Run Going?

Despite mixed recent news flow, Roche remains a company with significant potential.

NL

Article

TMFstockpicker published an article 11:28 AM

Can Bristol-Myers Squibb Keep Its Bull Run Going in 2014?

The year 2013 was a great one for Bristol-Myers Squibb (NYSE: BMY); 2014 could also be a strong year due to a potential catalyst.

Tue Mar 4

NL

Article

TMFstockpicker published an article 2:53 PM

Can Pfizer Overcome Its Patent Woes?

With patent expiry causing pressure on sales, Pfizer (NYSE: PFE) is attempting an alternative response.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 69638
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 0
Best Pick ( 0)
Worst Pick ( 0)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to XMFstockpicker’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show XMFstockpicker’s 10 Latest Posts